about
What proportion of Canadian women will accept an intrauterine contraceptive at the time of second trimester abortion? Baseline data from a randomized controlled trial.Measuring interprofessional competencies and attitudes among health professional students creating family planning virtual patient casesRegulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.Do you have a secret researcher inside?: High-quality family medicine research at Family Medicine Forum.Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS).The perspective of rural physicians providing abortion in Canada: qualitative findings of the BC Abortion Providers Survey (BCAPS)Immediate vs. delayed insertion of intrauterine contraception after second trimester abortion: study protocol for a randomized controlled trialCanadian Contraception Consensus (Part 1 of 4).Canadian Contraception Consensus (Part 2 of 4).Consensus canadien sur la contraception (3(e) partie de 4) : chapitre 8 - contraception à progestatif seul.Medical Abortion.Validating abortion procedure coding in Canadian administrative databasesThe effects of asking a fertility intention question in primary care settings: a systematic review protocol.Comparing the effectiveness of copper intrauterine devices available in Canada. Is FlexiT non-inferior to NovaT when inserted immediately after first-trimester abortion? Study protocol for a randomized controlled trialFirst-trimester medical abortion practices in Canada: National surveyAbortion health services in Canada: Results of a 2012 national surveyAccess to Complex Abortion Care Service and Planning Improved through a Toll-Free Telephone Resource Line.Inter-pregnancy interval and pregnancy outcomes among women with delayed childbearing: protocol for a systematic review.Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.Preventing repeat abortion in Canada: is the immediate insertion of intrauterine devices postabortion a cost-effective option associated with fewer repeat abortions?IUD String Perforation Through Anterior Cervix: A Case Report.The Rising Challenge of Training Physician-Scientists: Recommendations From a Canadian National Consensus Conference.No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception.Making a case for abortion curriculum reform: a knowledge-assessment survey of undergraduate medical students.Canadian Contraception Consensus (Part 3 of 4): Chapter 8 - Progestin-Only Contraception.The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.Abortion by telemedicine: an equitable option for Irish women.First trimester medication abortion practice in the United States and Canada.Requiring physicians to dispense mifepristone: an unnecessary limit on safety and access to medical abortion.A systematic review of the effect of reproductive intention screening in primary care settings on reproductive health outcomes.Induced abortion in Canada 1974-2005: trends over the first generation with legal access.Our struggle to implement best practices: the example of antibiotic prescription for respiratory tract infection.Second-Trimester Surgical Abortion Practices in the United States.No 329-Consensus canadien sur la contraception (4e partie de 4) : chapitre 9 – contraception hormonale combinée.Telemedicine and medical abortion: dispelling safety myths, with facts.Non-use of Contraception by Canadian Youth Aged 15 to 24: Findings From the 2009-2010 Canadian Community Health SurveyAssociation of Short Interpregnancy Interval With Pregnancy Outcomes According to Maternal AgeAbortion care in Canada is decided between a woman and her doctor, without recourse to criminal lawA Review of Therapeutic Abortions and Related Areas of Concern in CanadaA review of therapeutic abortions and related areas of concern in Canada
P50
Q30738125-40956BBE-9F5D-4912-A78B-897FB13C6639Q30824381-9B22D05A-CD1F-4246-9A27-EE26258C4255Q31151315-820C5B1D-4B2A-4123-93EA-613210F11563Q33894703-164DFB50-67CE-4B2B-8417-5D54DAC05D66Q34806297-6C79AFA7-4D7A-41EF-9371-6A5D6B4DCF61Q34806411-6DED7433-3C1B-49AB-BD69-74FB0A89E29CQ35121747-47649DB0-4F6E-4478-8678-6B6427F87ECCQ35852704-9C678605-DAD7-48DD-87B5-4C962F6C6114Q35858523-70F47F62-50C7-40DB-B20A-752342A1F4F7Q35997261-0B396C01-E234-4E59-BB92-C7DE4008A45AQ36025205-0FFB95D2-9158-4416-8D07-493D407EED18Q36074316-43BDA5DF-EE02-4096-95A0-10B1E2BC1407Q36254621-98C42AFA-0BA7-4BED-BC5E-307C3B553847Q36391173-268AE021-36F5-403E-9057-052F9BB98B29Q36795355-BF12C71E-CA5C-4D7C-843F-3F46855694C3Q36795360-EA7193A1-A330-4130-A6C2-161BF614FD92Q37623703-F2F9D479-4271-4812-9596-22DF676CFAEAQ37742482-40E4D671-DE63-467E-8C2F-11F48D9525DAQ37836887-71A163FD-48E0-4257-AC0A-3F187DE7FB47Q37954037-EFA82DD8-ACA3-4E25-9489-F586A272E49BQ38498382-4DF0F6A5-7421-4266-BC1F-1EA2BC62C67BQ38640971-247D5B71-6523-44A9-985C-E92328F399F1Q38835193-D0693411-1140-45F9-997B-8188B934911BQ39789162-B43FF0F7-5864-44DC-9DF4-099A5AE1454BQ39829289-B3532818-6564-414B-A3DD-2F052071B2C3Q40267148-476A8952-6554-410A-8365-CEDBE8BE59F6Q42350819-3D7DAF93-1883-48AF-AFEE-37FA5FE34B58Q43260518-44049611-5AFB-408F-B436-C6694287D9C9Q46190911-BD2217A9-FBAA-4EE5-9083-72AF2B72379DQ47668201-E79D2C57-A0AC-4E3B-A580-B03AA1F65BE7Q50166682-926450EE-6969-480B-BADB-9C4641C33230Q51613820-B64D3FEF-5CFD-42B8-81DA-0AEEF55E17BCQ52582761-12D82CA1-8655-4090-8FF0-C9B2BAE6DDA8Q53836651-2F1F54AF-2FC7-465A-8E0B-AB2F82CBCDA4Q55273329-C6E85EED-A7B4-47E2-BA2A-492A25140EE6Q57478555-B68A2E23-DC71-45CA-8187-D939DC44CAC2Q58105047-CDB76FCE-4436-4111-BD01-D0EAE85C7CD6Q59140085-1615CD6F-336C-4A20-B725-62B1F231B149Q59140148-ED4CB262-03F9-4E71-B871-BC04C4753BDCQ59140151-00F8C217-D001-4E47-82A2-2D064042CD6C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Wendy V Norman
@ast
Wendy V Norman
@en
Wendy V Norman
@es
Wendy V Norman
@nl
type
label
Wendy V Norman
@ast
Wendy V Norman
@en
Wendy V Norman
@es
Wendy V Norman
@nl
altLabel
Norman WV
@en
prefLabel
Wendy V Norman
@ast
Wendy V Norman
@en
Wendy V Norman
@es
Wendy V Norman
@nl
P106
P1153
42962175800
P31
P496
0000-0003-4340-7882